Barinthus Biotherapeutics plc ( BRNS) - Stock Earnings
Stock symbol BRNS is outdated, potentially delisted? Maybe it is available on other exchange?
BRNS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 6, 2026, midnight | — / — | — | — / — | — |
BRNS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -11.1 million USD | — USD |
| 2026Q1 | -5.5 million USD | — USD |
| 2026Q2 | -10.6 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BRNS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -73.3 million USD | 802000 USD |
| 2024 | -61.1 million USD | 15.0 million USD |
| 2025 | -66.6 million USD | — USD |
| 2026 Est. | — | — |
BRNS
Price: $0.74
52 week price:
Earnings Per Share: -1.03 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 31.0 million